These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2174515)

  • 1. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity.
    Yoshimura A; Longmore G; Lodish HF
    Nature; 1990 Dec; 348(6302):647-9. PubMed ID: 2174515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin receptor binds to Friend virus gp55 through other membrane components.
    Kishi A; Chiba T; Sugiyama M; Machide M; Nagata Y; Amanuma H; Taira H; Katsumata T; Todokoro K
    Biochem Biophys Res Commun; 1993 May; 192(3):1131-8. PubMed ID: 8507186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired activation and binding of the erythropoietin receptor by a mutant gp55 of Friend spleen focus-forming virus, which has a cytoplasmic domain.
    Yugawa T; Amanuma H
    Virology; 1998 Jul; 246(2):232-40. PubMed ID: 9657942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
    Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
    J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation.
    Gobert S; Chretien S; Gouilleux F; Muller O; Pallard C; Dusanter-Fourt I; Groner B; Lacombe C; Gisselbrecht S; Mayeux P
    EMBO J; 1996 May; 15(10):2434-41. PubMed ID: 8665851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
    Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
    EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor.
    Yoshimura A; Zimmers T; Neumann D; Longmore G; Yoshimura Y; Lodish HF
    J Biol Chem; 1992 Jun; 267(16):11619-25. PubMed ID: 1317872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.
    Hoatlin ME; Kozak SL; Lilly F; Chakraborti A; Kozak CA; Kabat D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9985-9. PubMed ID: 2175917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
    Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
    Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
    Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
    Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase activation through the extracellular domains of cytokine receptors.
    Chiba T; Nagata Y; Machide M; Kishi A; Amanuma H; Sugiyama M; Todokoro K
    Nature; 1993 Apr; 362(6421):646-8. PubMed ID: 8464516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain.
    Constantinescu SN; Liu X; Beyer W; Fallon A; Shekar S; Henis YI; Smith SO; Lodish HF
    EMBO J; 1999 Jun; 18(12):3334-47. PubMed ID: 10369674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.
    Barber DL; DeMartino JC; Showers MO; D'Andrea AD
    Mol Cell Biol; 1994 Apr; 14(4):2257-65. PubMed ID: 8139531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130.
    Yoshimura A; Lodish HF
    Mol Cell Biol; 1992 Feb; 12(2):706-15. PubMed ID: 1310150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally essential cytoplasmic domain of the erythropoietin receptor.
    Chiba T; Kishi A; Sugiyama M; Amanuma H; Machide M; Nagata Y; Todokoro K
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1236-41. PubMed ID: 1324661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors.
    Miura O; Cleveland JL; Ihle JN
    Mol Cell Biol; 1993 Mar; 13(3):1788-95. PubMed ID: 8382775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains.
    D'Andrea AD; Yoshimura A; Youssoufian H; Zon LI; Koo JW; Lodish HF
    Mol Cell Biol; 1991 Apr; 11(4):1980-7. PubMed ID: 1848667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.